Role of Nutritional Intervention in Critically Ill Child

Status Not yet recruiting

Clinical Trial Summary

- Assess the nutritional status of critically ill children using different nutritional assessment tools in management. - Assess accuracy and validity of screening tools in diagnosis of malnutrition by the following: - Strong kids - Stamp - PYMS - Assess the effect of early versus late enteral nutrition on the outcome and predict the complication associated with enteral feeding.

Clinical Trial Description

Malnutrition affects millions of children throughout the World. According to ESPEN nutritional risk screening tools have been designed to detect protein and energy under nutrition and predict if under nutrition may develop or worsen. The Screening was validated Tool for Assessment of Malnutrition in Pediatrics (STAMP) that evaluates patient's clinical diagnosis, nutritional intake during hospitalization and anthropometric measurements, developing a care plan based on the child's overall malnutrition risk. The Screening Tool for Impaired Nutritional Status and Growth (STRONG kids) consists of four items: clinical assessment, high-risk diseases, nutritional intake and losses, weight loss or poor weight gain. The Pediatric Yorkhill Malnutrition Score (PYMS) is adopted among patients between 1 and 16 years of age assesses four items: BMI, history of recent weight loss, changes in nutritional intake and the expected effect of current medical condition on patient's nutritional status. Indirect calorimetry, calculated from analysis of the inspired and expired gases, is the best method for evaluating individual energy expenditure. Protein requirements are highe. The catabolic effects of illness lead to negative nitrogen balance. Randomized protein-supplemented enteral diet achieved 3.1g/kg/day protein and positive nitrogen balance by PICU day 5. Enteral nutrition is more physiological, simpler, can be started more quickly and cheaper, it does not require special preparation, and it can be started and modified at any time. Par enteral nutrition has reserved for those patients with intestinal obstruction or severe gastrointestinal damage, ischemia, inflammation, hemorrhage, peritonitis and paralytic ileus. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04862728
Study type	Observational [Patient Registry]
Source	Assiut University
Contact	Hanan Hamdallah
Phone	00201011540871
Email	drsmart8989@gmail.com
Status	Not yet recruiting
Phase
Start date	June 2021
Completion date	September 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04515940` - Acceptability and Tolerance Study of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children
Completed	`NCT05244785` - Health and Nutrition Survey on Shenzhen Children
Enrolling by invitation	`NCT04150120` - eHealth as an Aid for Facilitating and Supporting Self-management in Families With Long-term Childhood Illness	N/A
Not yet recruiting	`NCT06065904` - Randomized One-Center Controlled Trial on a Comprehensive Nutritional Intervention for Children With Cerebral Palsy and ASD	N/A
Active, not recruiting	`NCT03509155` - Food Supplement Treatment for Wasting Children in Indonesia	N/A
Completed	`NCT06356103` - Efficacy Of High Caloric Whey-Based Partially Hydrolyzed Formula On Undernourished Neurologically Impaired Children	N/A
Not yet recruiting	`NCT06356220` - GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)	N/A
Completed	`NCT03933709` - Effect of a Nutritional Support System for Improving Gross Motor Function in Cerebral Palsy	N/A
Completed	`NCT04609358` - Efficacy and Safety of the Algorithm for Enteral Nutrition Support	N/A
Completed	`NCT06427525` - The Effect of Mobile Application Supported Health Promotion Program on Obesity of Adolescents	N/A
Withdrawn	`NCT04247269` - Review of Enteral Formulas in Children
Not yet recruiting	`NCT03196453` - Fit Child - Clinical Study on Weight Control	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.